Technical University of Munich at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Technical University of Munich brings 6 presentations to ESGCT 2026 in Hamburg. Its work centres on engineered T cell receptors for cancer and for chronic viral infection, including off-the-shelf products with reduced tissue matching requirements. Other strands cover oncolytic adenoviruses in paediatric sarcoma and AAV delivery to heart tissue.
| Organization | ESGCT 2026 Attendance |
|---|---|
Technical University of Munich Munich, Germany | |
Munich technical university with research on engineered T cell receptors for cancer immunotherapy. | Chair Wed Oct 28 1:30pm–2:30pm Poster Wed Oct 28 1:30pm–3:30pm Targeted Gene Delivery of Cardiac Interstitial Cells Using AAV Poster Wed Oct 28 1:30pm–3:30pm YB-1-based oncolytic adenoviruses engage the cancer-immunity cycle in paediatric sarcoma: rational combination with CDK4/6 inhibition and B7-H3 CAR-T cells Poster Thu Oct 29 2:00pm–4:00pm Clinical translation of CRISPR-Cas9-mediated TCR-engineering for the prevention of viral infections Poster Thu Oct 29 2:00pm–4:00pm Generation of "off-the-shelf", HLA-reduced T-cell product for adoptive cellular therapies Poster Thu Oct 29 2:00pm–4:00pm Overcoming barriers for T-cell therapy of chronic hepatitis B virus infection Talk Thu Oct 29 4:00pm–6:00pm Engineering T cell receptors for clinical applications Cell therapies and CAR-TClinical trials and translation Chair Fri Oct 30 9:00am–10:30am SESSION 11a: Cardio & muscular gene therapy Rare and inherited disease |
Instantly find 20 buyers from Technical University of Munich
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction